Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,661 | -230,026 | -195,645 | -124,096 | -51,527 |
| Depreciation Amortization | 594 | 2,630 | 1,871 | 1,213 | 578 |
| Income taxes - deferred | -3,856 | -26,049 | N/A | N/A | N/A |
| Accounts receivable | 3,466 | -30,218 | -15,896 | -2,079 | N/A |
| Accounts payable and accrued liabilities | 4,383 | 6,798 | 5,055 | 8,982 | 5,914 |
| Other Working Capital | -1,551 | -15,710 | -10,208 | 3,492 | 1,764 |
| Other Operating Activity | -20,257 | 59,197 | 43,076 | -671 | -11,878 |
| Operating Cash Flow | $-33,882 | $-233,378 | $-171,747 | $-113,159 | $-55,149 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -229 | -3,430 | -3,010 | -1,605 | -657 |
| Purchase Sale Intangibles | -889 | -2,946 | -2,833 | -1,900 | N/A |
| Other Investing Activity | -1,219 | -3,243 | -2,833 | -1,900 | 0 |
| Investing Cash Flow | $-1,448 | $-6,673 | $-5,843 | $-3,505 | $-657 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 49,591 | 49,591 | 49,591 | N/A |
| Common Stock Issued | N/A | 778 | 516 | 234 | 3 |
| Other Financing Activity | -258 | 217,025 | 218,505 | -517 | -300 |
| Financing Cash Flow | $-258 | $267,394 | $268,612 | $49,308 | $-297 |
| Exchange Rate Effect | -82 | 6 | -23 | 45 | 30 |
| Beginning Cash Position | 466,544 | 439,195 | 439,195 | 439,195 | 439,195 |
| End Cash Position | 430,874 | 466,544 | 530,194 | 371,884 | 383,122 |
| Net Cash Flow | $-35,670 | $27,349 | $90,999 | $-67,311 | $-56,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,882 | -233,378 | -171,747 | -113,159 | -55,149 |
| Capital Expenditure | -229 | -3,430 | -3,010 | -1,605 | -657 |
| Free Cash Flow | -34,111 | -236,808 | -174,757 | -114,764 | -55,806 |